The Danish government’s push to let citizens buy medicines from countries outside the EU is drawing sharp criticism from Lif, ...

US pharma major Johnson & Johnson (NYSE: JNJ) has halted its Phase IIb AuTonomy study after posdinemab failed to achieve a ...

The US Food and Drug Administration (FDA) has approved Padcev (enfortumab vedotin-ejfv), a nectin-4 directed antibody-drug ...

Switzerland is becoming the benchmark for American drug prices, warns the trade body Interpharma. A new US model links ...

Swiss biosimilars and generics company Sandoz today announced the European launch of Afqlir (aflibercept), a 2 mg vial kit ...

Australian drugmaker Mayne Pharma last week revealed it has been notified by USA-based Cosette Pharmaceuticals that it had ...

A technology-driven drug discovery company that integrates large-scale human data and artificial intelligence through its ...

Last week Dutch firm Merus inked a deal with USA-based Halozyme for the latter’s ENHANZE technology to deliver cancer ...

UK pharma major AstraZeneca has announced plans to invest $2 billion to expand its long-standing manufacturing footprint in ...

US clinical-stage biotech Repare Therapeutics has announced an update on the announcement on November 14 of entering into of ...

The UK subsidiary Alnylam welcomed positive Final Draft Guidance issued by the National Institute for Clinical Health and ...

USA-based Valo Health, a company using human data and AI to accelerate drug discovery and development, has announced a ...